Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing family planning progress in exemplar countries: development of a conceptual framework and case study methodology.

BMJ global health·2026
Same author

Pharmacological investigations of newly synthesized oxazolones and imidazolones as COX-2 inhibitors.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society·2026
Same author

Federated Learning for Thoracic Disease Classification Using Convolutional Neural Networks and Differential Privacy.

Healthcare technology letters·2026
Same author

Meta-lens-based circularly polarized fixed-beam antenna for high-gain wideband millimeter-wave applications.

Scientific reports·2026
Same author

Electromagnetic Performance Characterization and Circuit-Level Modeling of a Miniaturized Meander-Line Antenna for Implantable and Wearable RFID Applications.

Sensors (Basel, Switzerland)·2026
Same author

Reliable ECG classification using parallel hybrid models with limited resources.

Scientific reports·2026
Same journal

A computational model of chemically- and mechanically-induced thrombus formation in cerebral aneurysms.

Computers in biology and medicine·2026
Same journal

An improved catch fish optimization based deep learning model for Parkinson disease classification using EEG signal.

Computers in biology and medicine·2026
Same journal

Assessing the robustness of evaluation metrics for synthetic ECG signal quality.

Computers in biology and medicine·2026
Same journal

Integrating stemness and epithelial-mesenchymal transition signatures with machine learning identifies RUNX1 as a therapeutic vulnerability in colorectal cancer.

Computers in biology and medicine·2026
Same journal

Differential regional textural attributes of tongue in normal and acidity patients in the light of traditional Chinese medicine.

Computers in biology and medicine·2026
Same journal

SC-MSDNet: Spatial-consistent multi-view self-distillation for retinal OCT classification.

Computers in biology and medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 7, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K

LADNET: An MRI-based deep learning approach for Alzheimer's disease detection.

Ubaid Ullah1, Shabana Habib2, Muhammad Islam3

  • 1Department of Computer Science, Government Post Graduate College Charsadda Bacha Khan University Charsadda, Pakistan.

Computers in Biology and Medicine
|April 5, 2026
PubMed
Summary
This summary is machine-generated.

A new Lightweight Alzheimer's Disease Net (LADNET) model accurately detects Alzheimer's disease (AD) using MRI scans. This deep learning approach offers high accuracy and efficiency for early diagnosis and potential cost reduction in clinical settings.

Keywords:
Alzheimer's diseaseDementiaLADNETMildModerateVery mild

More Related Videos

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

41.0K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K

Related Experiment Videos

Last Updated: Apr 7, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

41.0K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K

Area of Science:

  • Neurology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Alzheimer's disease (AD) is the most prevalent form of dementia, characterized by progressive cognitive decline.
  • Early diagnosis of AD is crucial for improving patient survival rates and management.
  • Deep learning (DL) shows promise in analyzing complex medical images for disease identification.

Purpose of the Study:

  • To design and evaluate the Lightweight Alzheimer's Disease Net (LADNET) model for accurate AD detection using MRI scans.
  • To classify different dementia severities: Mild Dementia (MD), Moderate Dementia (MDD), and Very Mild Dementia (VMD), alongside Non-Demented (ND) individuals.
  • To assess LADNET's performance against existing methods on a large, publicly available dataset.

Main Methods:

  • Development of the LADNET model, a lightweight deep learning architecture.
  • Utilizing magnetic resonance imaging (MRI) scans for AD detection and classification.
  • Performance evaluation on a Kaggle dataset comprising over six thousand images across four categories.

Main Results:

  • LADNET achieved 99.4% accuracy and 99% AUC, outperforming existing methods.
  • The model demonstrated a lightweight design with approximately 1.2 million parameters.
  • Achieved fast inference speed of 4.2 ms per image.

Conclusions:

  • LADNET shows strong potential for clinical deployment in early Alzheimer's disease detection.
  • The model's efficiency and accuracy can aid in extracting biomarker information from MRIs.
  • LADNET may contribute to reducing patient burden and diagnostic costs in AD management.